Clinical Trials Logo

Clinical Trial Summary

Overactive bladder syndrome (OAB) is defined by urgent and frequent urges to urinate associated with frequent night-time urination and sometimes urinary incontinence. Sacral neuromodulation (SNM) is now one of the second-line treatments for OAB. The mode of action of SNM is still poorly understood but a number of data from recent scientific literature suggest that SNM may act, among other things, by altering the balance of the autonomic nervous system (ANS) - located at the interface between the urinary tract and the brain structures regulating the functioning of the urinary tract. The aim of this study would therefore be to develop a predictive tool for the effectiveness of SNM.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06434831
Study type Interventional
Source University Hospital, Lille
Contact
Status Not yet recruiting
Phase N/A
Start date July 2, 2024
Completion date December 2, 2026

See also
  Status Clinical Trial Phase
Recruiting NCT05380856 - Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction N/A
Terminated NCT02357784 - Sacral Neuromodulation in Dual Incontinence: Ultrasound and Afferent Nerve Sensation Assessment N/A
Completed NCT06098963 - Preliminary Outcomes of Sacral Neuromodulation Applications; Tertiary-Center Experience in Turkey
Active, not recruiting NCT05543382 - Cycling Study With the Axonics System
Not yet recruiting NCT05903105 - Diversity in Patients With OAB
Completed NCT00959296 - Implantable Systems Performance Registry N/A